Corrigendum to “Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer” [Neoplasia. 2014 Aug;16(8):665-77] (Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer (2014) 16(8) (665–677), (S1476558614001031), (10.1016/j.neo.2014.07.009))

The authors regret the accidental errors in the panels of Figure 2D (4T1, SAHA, 2.5 µM), Figure 4E (cleaved caspase 3, YF 30 mg/kg) and Figure 6A (control group) in the originally published article. These errors did not affect the scientific conclusions of the article. The corrected versions of Fig. 2D, Figure 4E and Fig. 6A are provided below. The authors would like to apologise for any inconvenience caused. Fig. 2D[Figure presented] Fig. 4E[Figure presented] Fig. 6A[Figure presented] <Mingyao Liu: Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China; Center for Cancer and Stem Cell Biology, Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030; Yongxiang Zhao: Biological Targeting Diagnosis and Therapy Research Center, Guangxi Medical University, 22 Shuang Yong Rd. Nanning, Guangxi 530021, China; Zhengfang Yi: Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China.